However, identification of these patients suggests that other factors, rather than the excretory branch of the kidney graft, including inappropriate erythropoietin production resulting from delayed graft function or perhaps calcineurin inhibitor nephrotoxicity, may play a role in the pathogenesis of anemia. The gene discussed is EPO; the disease is anemia.